Caribou Biosciences, Inc.
- CRBU
- NASDAQ
- Biotechnology
- Allogeneic Cell Therapies
- CRISPR Gene Editing
- Oncology (Blood Cancers/Solid Tumors)
$0.47
Today +1.12%Quote Oct 16, 2026, 08:00 PM UTC
−64.13%over the last month
Max drawdown −65.7%From 1-month high −64.9%3 months −71.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$50.4M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$1.00
+112.8% from here
Floor
$0.44
5.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CRBUPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
97
Founded
2011